Sharps Technology's CEO Issues Shareholder Letter Highlighting Hungary Manufacturing Facility Expansion Plans to Increase SecureGard and SoloGard Product Supply and Revenue Thursday, 5th December at 10:00 am •Shareholder letter includes details about the $50+ million sales agreement with a US-based pharma company, plans for Hungary SoloGard manufacturing expansion, and expected delivery schedule
•Initial production and commercial deliveries to begin in Q1 2025
•Sales team has signed an agreement to sell and deliver current SecureGard 1mL and 3mL inventory, with shipments and revenue that began in early December
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more